{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:48:59Z","timestamp":1781747339552,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1070\/15"],"award-info":[{"award-number":["1070\/15"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.thromres.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T15:36:05Z","timestamp":1528731365000},"page":"67-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59"],"prefix":"10.1016","volume":"168","author":[{"given":"Adi","family":"Tabib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Hindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel","family":"Karbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Zelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batla","family":"Falach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8096-9900","authenticated-orcid":false,"given":"Dror","family":"Mevorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.thromres.2018.06.006_bb0005","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","article-title":"Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories","volume":"112","author":"de Latour","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1160\/TH07-04-0316","article-title":"Stroke in paroxysmal nocturnal haemoglobinuria: patterns of disease and outcome","volume":"98","author":"Poulou","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"19","key":"10.1016\/j.thromres.2018.06.006_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1538-7836.2011.04562.x","article-title":"Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"10","author":"Van Bijnen","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"5099","key":"10.1016\/j.thromres.2018.06.006_bb0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.7680492","article-title":"The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis","volume":"259","author":"Miyata","year":"1993","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.thromres.2018.06.006_bb0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2018.06.006_bb0040","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejpn.2015.07.001","article-title":"Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency","volume":"19","author":"Ben-Zeev","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"5","key":"10.1016\/j.thromres.2018.06.006_bb0045","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ana.24770","article-title":"Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation","volume":"80","author":"Mevorach","year":"2016","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cyto.b.20465","article-title":"The absolute counting of red cell-derived microparticles with red cell bead by flow rate based assay","volume":"76","author":"Nantakomol","year":"2009","journal-title":"Cytometry B Clin. Cytom."},{"issue":"2","key":"10.1016\/j.thromres.2018.06.006_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.thromres.2015.06.008","article-title":"Alterations in markers of coagulation and fibrinolysis in patients with paroxysmal nocturnal hemoglobinuria before and during treatment with eculizumab","volume":"136","author":"van Bijnen","year":"2015","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jth.13514","article-title":"Standardization of microparticle enumeration across different flow cytometry platforms: results of a multicenter collaborative workshop","volume":"15","author":"Cointe","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2018.06.006_bb0065","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.thromres.2018.06.006_bb0070","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2018.06.006_bb0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa","volume":"10","author":"Van Der Meijden","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2018.06.006_bb0080","first-page":"916","article-title":"The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms","volume":"102","author":"Shantsila","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09537104.2013.784248","article-title":"Monocytes circulate in constant reversible interaction with platelets in a [Ca2+]-dependent manner","volume":"25","author":"Shantsila","year":"2014","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.thromres.2018.06.006_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(88)80092-5","article-title":"Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers","volume":"85","author":"Simionatto","year":"1988","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2018.06.006_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.CIR.93.2.327","article-title":"Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model","volume":"93","author":"Olsen","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2018.06.006_bb0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2018.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.thromres.2018.06.006_bb0110","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.V98.6.1802","article-title":"Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase","volume":"98","author":"Wagener","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2018.06.006_bb0115","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH07-11-0691","article-title":"Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells","volume":"100","author":"Aharon","year":"2008","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2018.06.006_bb0120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2141.2004.04974.x","article-title":"Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria","volume":"125","author":"Simak","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2018.06.006_bb0125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2009.016121","article-title":"Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"95","author":"Helley","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.thromres.2018.06.006_bb0130","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/cdd.2013.113","article-title":"Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage","volume":"20","author":"Schaer","year":"2013","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.thromres.2018.06.006_bb0135","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V93.10.3451.410k27_3451_3456","article-title":"Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia","volume":"93","author":"Hugel","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2018.06.006_bb0140","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.thromres.2018.06.006_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0049-3848(96)00153-3","article-title":"Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria","volume":"83","author":"Maciejewski","year":"1996","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI112773","article-title":"Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo","volume":"79","author":"Devine","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.thromres.2018.06.006_bb0155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s002770100350","article-title":"Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuria","volume":"80","author":"Louwes","year":"2001","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.thromres.2018.06.006_bb0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-5699(91)90012-I","article-title":"The response of human platelets to activated components of the complement system","volume":"12","author":"Sims","year":"1991","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09537105310001657110","article-title":"The platelet function defect of paroxysmal nocturnal haemoglobinuria","volume":"15","author":"Grunewald","year":"2004","journal-title":"Platelets"},{"issue":"32","key":"10.1016\/j.thromres.2018.06.006_bb0170","doi-asserted-by":"crossref","first-page":"19228","DOI":"10.1016\/S0021-9258(19)47291-8","article-title":"Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex","volume":"264","author":"Sims","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.thromres.2018.06.006_bb0175","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","article-title":"Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria","volume":"82","author":"Wiedmer","year":"1993","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2018.06.006_bb0180","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/432729","article-title":"Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet\/neutrophil complexes","volume":"192","author":"Bryant","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.thromres.2018.06.006_bb0185","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0190","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1538-7836.2007.02379.x","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview","volume":"5","author":"Ziakas","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2018.06.006_bb0195","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.0000000000001391","article-title":"Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency","volume":"84","author":"Haliloglu","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1308104","article-title":"Targeted therapy with eculizumab for inherited CD59 deficiency","volume":"370","author":"Hochsmann","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2018.06.006_bb0205","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/eji.1830221029","article-title":"Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene","volume":"22","author":"Motoyama","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.thromres.2018.06.006_bb0210","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","article-title":"Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)","volume":"102","author":"Hall","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","article-title":"Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays","volume":"126","author":"Moyo","year":"2004","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molimm.2015.03.005","article-title":"Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: differences and similarities","volume":"67","author":"Mevorach","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2018.06.006_bb0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMc1707173","article-title":"Loss of CD55 in eculizumab-responsive protein-losing enteropathy","volume":"377","author":"Kurolap","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2018.06.006_bb0230","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7288.1","article-title":"Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria","volume":"5","author":"Luzzatto","year":"2016","journal-title":"F1000Research"},{"issue":"3","key":"10.1016\/j.thromres.2018.06.006_bb0235","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1067\/mcp.2003.13","article-title":"Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease","volume":"73","author":"Klinkhardt","year":"2003","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818303803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818303803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T13:03:05Z","timestamp":1661432585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818303803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":47,"alternative-id":["S0049384818303803"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.06.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}